ICOS Corporation

ICOS Corporation is developing proprietary biopharmaceuticals and small molecule pharmaceuticals for thetreatment of inflammatory diseases and other serious medical conditions. The Company's fundamental strategy is to identify and develop a significant number of potential product candidates into breakthrough products with high commercial potential. By understanding the underlying biochemical and physiological mechanisms and identifying the cellular and molecular entities involved in the disease process, ICOS is developing biopharmaceutical products that address important opportunities in the treatment of chronic and acute diseases that have inflammatory components as well as certain cardiovascular diseases and cancer. Through this strategy, the Company believes it will be able to develop novel therapeutics that are more selective and efficacious than current therapeutics.

Contact Details: 22021 20th Avenue SouthEast Bothell Washington 98021 United States of America Tel: 425 485 1900 Fax: 425 489 0356 Email: WWW: www.icos.com/

Loading...

Recent Publications by ICOS Corporation:
Novel tools for functional analysis of CD11c: activation-specific, activation-independent, and activating antibodies. Functions and binding properties of four CD11c-specific mAbs are described...	1st April, 2008	ICOS Corporation,	J Immunoassay Immunochem. 2008;29(1):42-57. DOI Direct Link
CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity. CD11c, a member of the leukointegrin family, is expressed prominently on...	18th September, 2007	ICOS Corporation, 22021 20th Ave., S.E., Bothell, WA 98021, USA.	J Leukoc Biol. 2007 Jun;81(6):1395-403. Epub 2007 Mar 27. DOI Direct Link
Enhancement of Natural Killer cell cytotoxicity by a CD18 integrin-activating antibody. Natural Killer (NK) cells kill certain tumor cells and virus infected...	21st July, 2007	ICOS Corporation, 22021 20th Avenue SE, Bothell, WA 98021, USA.	Biochem Biophys Res Commun. 2007 Jul 6;358(3):938-41. Epub 2007 May 14. DOI Direct Link
11 techniques to attract patients to your clinical research studies. Many physicians are searching for the "Holy Grail", i.e., the ability to...	15th June, 2007	ICOS Corporation, Cialis Product Team, Lilly-ICOS LLC, 22021 20th Avenue	J Med Pract Manage. 2007 Mar-Apr;22(5):267-8.
Investigations on solid-solid phase transformation of 5-methyl-2-[(4-methyl-2-nitrophenyl)amino]-3-thiophenecarbonitrile. Solid-solid transformation of...	15th June, 2007	Department of Industrial and Physical Pharmacy, 575 Stadium Mall Drive,	J Pharm Sci. 2007 May;96(5):1079-89. DOI Direct Link
→View more ICOS Corporation research publications.

BioNews Results for ICOS Corporation:
InvestSource, Inc.: 'Green Initiative' Launched With Diamant Art Corporation And 801 Packaging	Calibre Macro World:  Aug 28 2008 10:11AM Matching: icos
Discover Key Issues to Consider When Bringing Biologics to Market in Europe and Japan	Pharma Live:  Aug 20 2008 11:18AM Matching: icos
Alaska Food Diagnostics to accelerate the commercial roll-out of its revolutionary fastrAK pathogen detectio	BioPortfolio:  Aug 19 2008 10:45AM Matching: icos
Discover Key Issues to Consider When Bringing Biologics to Market in Europe and Japan	Business Wire via Yahoo!:  Aug 19 2008 4:06AM Matching: icos
Accelerator Corporation Creates Ninth Biotech Company - Takes Nanogen License to Create Novel Therapeutics	Nanotechnology News:  Aug 16 2008 8:54PM Matching: icos
Promote your company here: BioNewsCast - Press Release Distribution	→View more ICOS Corporation news.

ICOS Corporation Patents:
US Patent No.	Title
6667300	Inhibitors of human phosphatidylinositol 3-kinase delta
6821975	Beta-carboline drug products
6825197	Cyclic GMP-specific phosphodiesterase inhibitors
6838456	Condensed pyridoindole derivatives
6841167	.beta.-carboline pharmaceutical compositions
→View more ICOS Corporation patents.

ICOS Corporation (ICOS) Financial information Links from Barchart
ICOS Quote from from Barchart.com
ICOS Chart from from Barchart.com
ICOS Profile from from Barchart.com
ICOS Opinion from from Barchart.com
→View more ICOS Corporation finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 23 individuals from ICOS Corporation using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 261 times since April 2007, the link to the organisation's website has been followed 39 times

Recent Search Terms used to find this page: icos corporation | IC-83 ICOS | ICOS Corporation | IC83 | IC83 | ICOS pharma | tadalafil patent uk | IC83 clinical trial | beta carboline tadalafil patent | IC83 atr | .

Search for more companies in Bothell

Search for more companies in Washington

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ICOS Corporation